Alternative Dosing Regimens of GLP-1 Receptor Agonists May Reduce Costs and Maintain Weight Loss Efficacy
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Ambas sustancias reducen la activacin de la microgla, que son las clulas inmunitarias del sistema nervioso central que estn hiperactivas en la EM
That's your
Find your favorites and rotate to keep things fresh
Nonostante lefficacia di questi trattamenti, i pazienti, soprattutto i non diabetici, possono sviluppare sintomi a livello digestivo